Oncogene - Table of Contents alert Volume 31 Issue 19

TABLE OF CONTENTS Volume 31, Issue 19 (May 2012) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Reviews Cancer POSTER - MITOCHONDRIAL FUNCTION AND CANCER Author: Douglas C. Wallace This Poster highlights some recent discoveries that have led to a renewed interest in the function of mitochondria in cancer cells. Mitochondria carry out a number of crucial functions in cells and these can be altered through mutations in either the nuclear DNA or the mitochondrial DNA. Access the Poster FREE online! www.nature.com/nrc/posters/mitochondria This Poster is freely available thanks to sponsorship from Abcam   Review Top Deubiquitinases in cancer: new functions and therapeutic options J M Fraile, V Quesada, D Rodríguez, J M P Freije and C López-Otín Oncogene 2012 31: 2373-2388; advance online publication, September 26, 2011; 10.1038/onc.2011.443 Abstract | Full Text Original Articles Top TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer M-C Shih, J-Y Chen, Y-C Wu, Y-H Jan, B-M Yang, P-J Lu, H-C Cheng, M-S Huang, C-J Yang, M Hsiao and J-M Lai Oncogene 2012 31: 2389-2400; advance online publication, September 26, 2011; 10.1038/onc.2011.419 Abstract | Full Text Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling M-H Yang, B-R Lin, C-H Chang, S-T Chen, S-K Lin, M Y-P Kuo, Y-M Jeng, M-L Kuo and C-C Chang Oncogene 2012 31: 2401-2411; advance online publication, September 19, 2011; 10.1038/onc.2011.423 Abstract | Full Text Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance W Li and D W Melton Oncogene 2012 31: 2412-2422; advance online publication, September 26, 2011; 10.1038/onc.2011.426 Abstract | Full Text A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression M Zeineldin, J Cunningham, W McGuinness, P Alltizer, B Cowley, B Blanchat, W Xu, D Pinson and K L Neufeld Oncogene 2012 31: 2423-2437; advance online publication, September 26, 2011; 10.1038/onc.2011.434 Abstract | Full Text Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential C Y Darini, D F Pisani, P Hofman, F Pedeutour, I Sudaka, C Chomienne, C Dani and A Ladoux Oncogene 2012 31: 2438-2449; advance online publication, September 19, 2011; 10.1038/onc.2011.421 Abstract | Full Text Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest P Russell, B T Hennessy, J Li, M S Carey, R C Bast, T Freeman and A R Venkitaraman Oncogene 2012 31: 2450-2460; advance online publication, November 7, 2011; 10.1038/onc.2011.431 Abstract | Full Text Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells Y Cheli, S Giuliano, N Fenouille, M Allegra, V Hofman, P Hofman, P Bahadoran, J-P Lacour, S Tartare-Deckert, C Bertolotto and R Ballotti Oncogene 2012 31: 2461-2470; advance online publication, September 26, 2011; 10.1038/onc.2011.425 Abstract | Full Text Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells K J Basile, E V Abel and A E Aplin Oncogene 2012 31: 2471-2479; advance online publication, September 26, 2011; 10.1038/onc.2011.424 Abstract | Full Text Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8 D T N Shola, H Wang, R Wahdan-Alaswad and D Danielpour Oncogene 2012 31: 2480-2490; advance online publication, September 26, 2011; 10.1038/onc.2011.422 Abstract | Full Text Short Communication Top Identification of additional IDH mutations associated with oncometabolite R(−)-2-hydroxyglutarate production P S Ward, J R Cross, C Lu, O Weigert, O Abel-Wahab, R L Levine, D M Weinstock, K A Sharp and C B Thompson Oncogene 2012 31: 2491-2498; advance online publication, September 26, 2011; 10.1038/onc.2011.416 Abstract | Full Text Advertisement Take a look at this recent article published in Cancer Gene Therapy: Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models N-H Kang et al. Cancer Gene Therapy ¦ doi:10.1038/cgt.2012.15   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.